
Discover the challenges and opportunities of acquiring an Amazon FBA supplements business in this engaging episode with special guest Travis Jamison.
Discover the challenges and opportunities of acquiring an Amazon FBA supplements business in this engaging episode with special guest Travis Jamison.
This episode is brought to you by our sponsors:
Capital Pad: Your platform for connecting investors with searcher and independent sponsor deals. Learn more at https://www.capitalpad.com.
HoldCo Conference: The premier event for holding company entrepreneurs. Don't miss your chance to connect and learn. Visit https://www.holdcoconf.com for details.
Travis Jamison joins the show to break down an Amazon FBA supplements business listed for a whopping 10x multiple. With his deep expertise in e-commerce and Amazon FBA, Travis explores the risks and rewards of buying into a highly competitive niche. We discuss supply chain strategies, the sustainability of growth claims, and why some FBA deals might not be worth the risk—plus insights into more resilient investment opportunities.
Key Highlights:
- Introduction to Travis Jamison and his e-commerce background.
- Overview of the Amazon FBA supplements business listing and its valuation.
- Insights into the cutthroat nature of Amazon's supplements niche.
- The role of pricing, branding, and operational efficiency in the business.
- Strategies for evaluating growth potential and avoiding pitfalls in acquisitions.
- Exploring alternative, stable business opportunities on platforms like Capital Pad.

Interested in buying a franchise? Check out Connor's website here: https://connorgroce.com/lander

In this episode the hosts dig into a $7.1 M cash‑price listing for a specialty pharmacy in Beverly Hills — evaluating its 1.49 M EBITDA, market position and regulatory complexity to see whether it’s a viable acquisition.

In this episode the hosts walk through evaluating a potential acquisition of a Houston‑area elevator services company, debating whether a 7.5× EBITDA asking price can pencil out given the financing constraints and growth challenges.